Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 11, 2015, Pages 1666-1672

  Chen, Lu ^a,b   Li, Christopher I ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR;

ADULT; ADVANCED CANCER; AFRICAN AMERICAN; AGED; ALASKA NATIVE; AMERICAN INDIAN; ARTICLE; BREAST CANCER; CANCER REGISTRY; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH DISPARITY; HIGH RISK PATIENT; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; RACE DIFFERENCE; TRIPLE NEGATIVE BREAST CANCER; ASIAN AMERICAN; BREAST NEOPLASMS; CANCER STAGING; ETHNOLOGY; GENETICS; GENOTYPE; HEALTH CARE DISPARITY; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; TRIPLE NEGATIVE BREAST NEOPLASMS; UNITED STATES; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SEER PROGRAM; TRIPLE NEGATIVE BREAST NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84946564463     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0293     Document Type: Article

References (57)

1. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56.
2. Banegas MP, Li CI. Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat 2012;134:1297-304.
3. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 2011;127:729-38.
4. Hershman D, McBride R, Jacobson JS, Lamerato L, Roberts K, Grann VR, et al. Racial disparities in treatment and survival among women with earlystage breast cancer. J Clin Oncol 2005;23:6639-46.
5. Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, et al. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data. Cancer Causes Control 2014;25:959-68.
6. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
7. Tannenbaum SL, Koru-Sengul T, Miao F, Byrne MM. Disparities in survival after female breast cancer diagnosis: a population-based study. Cancer Causes Control 2013;24:1705-15.
8. Altekruse S, Kosar C, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (eds). SEER Cancer Statistics Review 1975-2007, National Cancer Institute; accessed 12 Jan 2015, Bethesda, MD. Available from: http://seer.cancer. gov/csr/1975-2007.
9. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review (CSR) 1975-2011 National Cancer Institute; accessed 12 Jan 2015, Bethesda, MD. Available from: http://seer. cancer.gov/archive/csr/1975-2011.
10. Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, et al. Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 2013;310:389-97.
11. Lepeak L, Tevaarwerk A, Jones N, Williamson A, Cetnar J, LoConte N. Persistence in breast cancer disparities between African Americans and whites in Wisconsin. WMJ 2011;110:21-5.
12. Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol 2005;23:7836-41.
13. DeLancey JOL, Thun MJ, Jemal A, Ward EM. Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev 2008;17:2908-12.
14. Dawood S, Broglio K, Gonzalez-Angulo AM, Buzdar AU, Hortobagyi GN, Giordano SH. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol 2008;26:4891-8.
15. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 2014;28:106 (5). pii: dju055.
16. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-502.
17. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007;13:4429-34.
18. Sturtz LA, Melley J, Mamula K, Shriver CD, Ellsworth RE. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC Cancer 2014;14:62.
19. Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong Y-N, Edge SB, et al. Racial and ethnic differences in breast cancer survival: Mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 2015;33:2254-61.
20. Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 2009;113:357-70.
21. Parise CA, Caggiano V. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. BMC Cancer 2013;13:449.
22. Tao L, Gomez SL, Keegan THM, Kurian AW, Clarke CA. Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomarkers Prev 2015;24:1039-45
23. Parise C, Caggiano V. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California. Cancer Epidemiol 2014;38:556-62.
24. Telli ML, Chang ET, Kurian AW, Keegan THM, McClure LA, Lichtensztajn D, et al. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat 2011;127:471-8.
25. Kurian AW, Fish K, Shema SJ, Clarke CA. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res 2010;12:R99.
26. National Cancer Insitute. Breast subtype (2010+), accessed on 28 May 2015. Available from: http://seer.cancer.gov/seerstat/databases/ssf/breastsubtype.html.
27. Wu X-C, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, et al. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 2012;30:142-50.
28. Chang SW, Kerlikowske K, Nápoles-Springer A, Posner SF, Sickles EA, Pérez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 1996;78:1395-402.
29. Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 2006;144:541-53.
30. Overview of the SEER Program accessed 22 Jan 2015. Available from: http://seer.cancer.gov/about/overview.html.
31. National Cancer Institute. Derived HER2 recode (2010+) - SEER documentation, accessed 20 Feb. 2015 Available from: http://seer.cancer.gov/seerstat/databases/ssf/her2-derived.html.
32. National Comprehensive Cancer Network (NCCN). NCCN Guidelines, Version 3; 2013, accessed 20 Feb. 2015. Invasive breast cancer. Available from: http://www.nccn.org/professionals/physician-gls/f-guidelines.aspite.
33. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
34. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10, 801 women in 17 randomised trials. Lancet 2011;378:1707-16.
35. McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 2001;19:3938-43.
36. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002;40:49-54.
37. McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 2000;48:1226-33.
38. Hahn KME, Bondy ML, Selvan M, Lund MJ, Liff JM, Flagg EW, et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol 2007;166:1035-44.
39. Yasmeen S, Xing G, Morris C, Chlebowski RT, Romano PS. Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer 2011;117:3252-61.
40. Martínez ME, Nielson CM, Nagle R, Lopez AM, Kim C, Thompson P. Breast cancer among Hispanic and non-Hispanic White women in Arizona. J Health Care Poor Underserved 2007;18:130-45.
41. Roen EL, Copeland GE, Pinagtore NL, Meza R, Soliman AS. Disparities of cancer incidence in Michigan's American Indians: spotlight on breast cancer. Cancer 2014;120:1847-53.
42. Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, et al. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer 2008;113:1191-202.
43. Keating NL, Kouri E, He Y, Weeks JC, Winer EP. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 2009;47:765-73.
44. Mandelblatt JS, Kerner JF, Hadley J, Hwang Y-T, Eggert L, Johnson LE, et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer 2002;95:1401-14.
45. Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, et al. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 2011;117:180-9.
46. Ambrosone CB, Zirpoli G, Ruszczyk M, Shankar J, Hong C-C, McIlwain D, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Cancer Causes Control 2014;25:259-65.
47. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011;103:470-7.
48. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002;94:490-6.
49. Komenaka IK, Martinez ME, Pennington RE, Hsu C-H, Clare SE, Thompson PA, et al. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst 2010;102:1178-87.
50. Sineshaw HM, Gaudet M, Ward EM, Flanders WD, Desantis C, Lin CC, et al. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011). Breast Cancer Res Treat 2014;145:753-63.
51. Rodríguez MA, Ward LM, Pérez-Stable EJ. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med 2005;3:235-41.
52. Breen N, Rao SR, Meissner HI. Immigration, health care access, and recent cancer tests among Mexican-Americans in California. J Immigr Minor Health 2010;12:433-44.
53. Mack KP, Pavao J, Tabnak F, Knutson K, Kimerling R. Adherence to recent screening mammography among Latinas: Findings from the California Women's Health Survey. J Womens Heal 2009;18:347-54.
54. Miller JW, King JB, Joseph DA, Richardson LC. Breast cancer screening among adult women-behavioral risk factor surveillance system, United States, 2010. MMWR 2012;61:46-50.
55. Javid SH, Varghese TK, Morris AM, Porter MP, He H, Buchwald D, et al. Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients. Cancer 2014;120:2183-90.
56. Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, et al. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat 2012;131:607-17.
57. Reeder-Hayes KE, Meyer AM, B Dusetzina S, Liu H, Wheeler SB. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer. Breast Cancer Res Treat 2014;145:743-51.